BERYLLIUM SULFATE
- CAS NO.:13510-49-1
- Empirical Formula: Be.H2O4S
- Molecular Weight: 107.09
- EINECS: 236-842-2
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-05-04 15:15:19
What is BERYLLIUM SULFATE?
Chemical properties
Colorless crystals. Soluble in water; insoluble in alcohol.
Physical properties
Colorless crystalline solid; tetragonal crystal system; hygroscopic; density 2.50 g/cm3 (tetrahydrate 1.71 g/cm3); tetrahydrated salt loses water of crystallization on heating; further heating to 550°C causes decomposition; soluble in water, tetrahydrate more soluble in water (30.5g/100g at 30°) than the anhydrous salt; insoluble in alcohol.
The Uses of BERYLLIUM SULFATE
No major commercial application of beryllium sulfate is known.
The Uses of BERYLLIUM SULFATE
Beryllium sulfate is an important salt of beryllium used as an intermediate of high purity for calcination to beryllium oxide powder for ceramic applications. A saturated aqueous solution of beryllium sulfate contains 30.5% BeSO4 by weight at 30 °C and 65.2% at 111 °C.
Definition
ChEBI: A metal sulfate in which the metal is beryllium (in the +2 oxidation state) and the ratio of beryllium to sulfate is 1:1.
Preparation
Beryllium sulfate may be prepared by treating an aqueous solution of any beryllium salt with sulfuric acid, followed by evaporation of the solution and crystallization. The hydrated product may be converted to anhydrous salt by heating at 400°C.
General Description
Colorless, odorless crystals. Highly toxic by inhalation and ingestion. Sinks and mixes with water.
Air & Water Reactions
Soluble in water.
Reactivity Profile
BERYLLIUM SULFATE is incompatible with the following: Acids, caustics, chlorinated hydrocarbons, oxidizers, molten lithium .
Hazard
A confirmed carcinogen.
Health Hazard
Any dramatic, unexplained weight loss should be considered as possible first indication of beryllium disease. Other symptoms include anorexia, fatigue, weakness, malaise. Inhalation causes pneumonitis, nasopharyngitis, tracheobronchitis, dyspnea, chronic cough. Contact with eyes causes conjunctival inflammation. Contact with skin causes dermatitis of primary irritant or sensitization type; causes ulcer formation when in contact with cuts.
Fire Hazard
Special Hazards of Combustion Products: Toxic beryllium oxide and sulfuric acid fumes may form in fire.
Safety Profile
Confirmed carcinogen withexperimental tumorigenic data. Acute poison byinhalation, ingestion, intraperitoneal, subcutaneous,intravenous, and intratracheal routes. Mutation data reported. When heated to decomposition itemits very toxic fumes of SOx an
Properties of BERYLLIUM SULFATE
Melting point: | 1127°C |
Density | 2.500 |
form | colorless tetragonal crystals |
color | Colorless, tetragonal, hygroscopic crystals |
Water Solubility | g/100g solution H2O: 26.69 (0°C), 29.22 (25°C), 45.28 (100°C); solid phase, BeSO4 · 4H2O [KRU93]; insoluble alcohol [HAW93] |
EPA Substance Registry System | Beryllium sulfate (13510-49-1) |
Safety information for BERYLLIUM SULFATE
Computed Descriptors for BERYLLIUM SULFATE
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%View Details
99903-60-3 -
88491-46-7 98%View Details
88491-46-7 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4